Science & Technology
Phase 1 Clinical Trial to Assess the Pharmacokinetics, Safety and Tolerance of a Zanamivir Transdermal System in Healthy Subjects
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1U44AI184201-01
Award Ceiling
$293K
Award Floor
$293K
Close Date
Dec 31, 2024
Total Funding
$293K
Expected Awards
1
Posted Date
Jul 10, 2024
Cost Sharing Required
No
Grants.gov ID
sbir-1U44AI184201-01
Description
SBIR Phase Phase I award: "Phase 1 Clinical Trial to Assess the Pharmacokinetics, Safety and Tolerance of a Zanamivir Transdermal System in Healthy Subjects" awarded to TSRL, INC. in ANN ARBOR, Michigan. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $292,746. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.